Cargando…

Isoproterenol suppresses recurrent torsades de pointes in a patient with long QT syndrome type 2

Detalles Bibliográficos
Autores principales:	Suarez, Keith, Mack, Ryan, Hardegree, Evan L., Chiles, Christopher, Banchs, Javier E., Gonzalez, Mario D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6301889/ https://www.ncbi.nlm.nih.gov/pubmed/30581736 http://dx.doi.org/10.1016/j.hrcr.2018.08.013

Ejemplares similares

Acquired Long QT Syndrome and Electrophysiology of Torsade de Pointes
por: El-Sherif, Nabil, et al.
Publicado: (2019)

DOTHIEPIN, QT PROLONGATION AND TORSADES DE POINTES
por: Andrade, Chittaranjan, et al.
Publicado: (1999)

Recurrent takotsubo with prolonged QT and torsade de pointes and left ventricular thrombus
por: Ahmed, Alaa Eldin K., et al.
Publicado: (2017)

Long QT Syndrome and Torsade de Pointes Associated with Takotsubo Cardiomyopathy
por: Ahn, Ji Hun, et al.
Publicado: (2011)

Long QT syndrome and torsade de pointes after anthracycline chemotherapy
por: Colombo, N, et al.
Publicado: (2009)

QT prolongation and torsades de pointes with psychotropic agents
por: Desai, Nagaraj, et al.
Publicado: (2015)

QT Dispersion and Drug-Induced Torsade de Pointes
por: Friedman, Ari, et al.
Publicado: (2021)

Successful treatment of bepridil-induced intraoperative torsades de pointes by isoproterenol infusion
por: Shimano, Ken, et al.
Publicado: (2021)

Acquired Long QT Syndrome and Torsade de Pointes Associated with HIV Infection
por: Shimabukuro-Vornhagen, Alexander, et al.
Publicado: (2010)

Drug-Induced Long-QT and Torsades de Pointes in Elderly Polymedicated Patients
por: García-Fuertes, Daniel, et al.
Publicado: (2016)

Long QT syndrome and torsades de pointes complicating mitral valve replacement
por: Gilbert, Shegu, et al.
Publicado: (2016)

Propofol abolishes torsade de pointes in different models of acquired long QT syndrome
por: Ellermann, Christian, et al.
Publicado: (2020)

QT interval prolongation and Torsades de Pointes with donepezil, rivastigmine and galantamine
por: Malone, Katie, et al.
Publicado: (2020)

Torsades de pointes observed in the early postoperative period in a patient with long QT syndrome
por: Kim, Min-Soo, et al.
Publicado: (2013)

PARP inhibitor-induced torsades de pointes in long QT syndrome: a case report
por: Segan, Louise, et al.
Publicado: (2019)

Long QT-Syndrome With Torsades de Pointes Managed Considering Financial Constraints Faced by the Patient
por: Patel, Ramesh, et al.
Publicado: (2021)

Landiolol suppression of electrical storm of torsades de pointes in patients with congenital long-QT syndrome type 2 and myocardial ischemia
por: Kitajima, Ryota, et al.
Publicado: (2017)

Chloroquine/erythromycin: QT interval prolongation and Torsade de Pointes: case report
Publicado: (2020)

Postanesthetic torsade de pointes in a patient with unrecognized long QT syndrome -A case report-
por: Lee, Jae-Young, et al.
Publicado: (2011)

Acquired Long QT Syndrome Manifesting with Torsades de Pointes in a Patient with Panhypopituitarism due to Radiotherapy
por: Kang, Dae Gil, et al.
Publicado: (2013)

Recurrent Torsades with Refractory QT Prolongation in a 54-Year-Old Man
por: Guess, Joel, et al.
Publicado: (2018)

Diagnosing Torsades De Pointes Based on Correlation to QT Interval: A Systematic Review
por: Kahlon, Simranjit S, et al.
Publicado: (2022)

DRUGS, ELECTROLYTES AND TAKO-TSUBO CARDIOMYOPATHY: TRIPLE AETIOLOGY OF ACQUIRED LONG QT SYNDROME AND TORSADES DE POINTES
por: Purvis, John A, et al.
Publicado: (2009)

Torsades de Pointes During Myringotomy in a Child with Congenital Long QT Syndrome: A Case Report
por: Coleman, Melissa, et al.
Publicado: (2020)

Suppression of cardiac memory–related severe form of torsades de pointes by landiolol in a patient with congenital long QT syndrome type 2
por: Otsuki, Sou, et al.
Publicado: (2020)

Shock From Twisting Peaks: A Rare Case of Recurrent Torsades de Pointes Secondary to Leuprolide-Induced Prolonged QT
por: Abbasi, Danish, et al.
Publicado: (2020)

Voltage/Calcium Uncoupling Underlies Sustained Torsade de Pointes Ventricular Tachyarrhythmia in an Experimental Model of Long QT Syndrome
por: Himel, Herman D., et al.
Publicado: (2021)

QT Interval Prolongation as a Biomarker for Torsades de Pointes and Sudden Death in Drug Development
por: Sides, Gregory D.
Publicado: (2002)

Torsades de pointes induced by concomitant use of chlorpheniramine and propranolol: An unusual presentation with no QT prolongation
por: Ösken, Altuğ, et al.
Publicado: (2016)

Torsades de Pointes associated with QT prolongation after catheter ablation of paroxysmal atrial fibrillation
por: Park, Yae Min, et al.
Publicado: (2017)

The Incidence of QT Prolongation and Torsades des Pointes in Patients Receiving Droperidol in an Urban Emergency Department
por: Cole, Jon B., et al.
Publicado: (2020)

QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine/azithromycin
por: Chorin, Ehud, et al.
Publicado: (2020)

Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine
por: Sarayani, Amir, et al.
Publicado: (2021)

Mechanisms of fever-induced QT prolongation and torsades de pointes in patients with KCNH2 mutation
por: Usuda, Keisuke, et al.
Publicado: (2023)

Successful Management of Refractory Torsades De Pointes Due to Drug-Induced Long QT Syndrome Guided by Point-of-Care Monitoring of Ionized Magnesium
por: Matsuura, Chiho, et al.
Publicado: (2021)

QT Prolongation Complicated with Torsades de Pointes in Prosthetic Mitral Valve Endocarditis: A Case Report
por: Tounsi, A., et al.
Publicado: (2012)

QT interval prolongation and torsade de pointes: Synergistic effect of flecainide and H(1) receptor antagonists
por: Acosta-Materán, Carlos, et al.
Publicado: (2016)

Risk of QT prolongation and torsade de pointes associated with exposure to hydroxyzine: re‐evaluation of an established drug
por: Schlit, Anne‐Françoise, et al.
Publicado: (2017)

A Case of Hypoglycemiainduced QT Prolongation Leading to Torsade de Pointes and a Review of Pathophysiological Mechanisms
por: Hannoodi, Faris, et al.
Publicado: (2017)

Ceftriaxone/hydroxychloroquine/tocilizumab: QT prolongation, torsade-de-pointes and off label use: case report
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_54ifgcfuvfnai9b69n2r11q20b